Nivolumab Shows Promise in Advanced Metastatic Anal Cancer Nivolumab Shows Promise in Advanced Metastatic Anal Cancer

The immunotherapy may extend overall survival better than current therapies and offers something new in anal cancer ' for the first time in 20 years, ' says editorialist.Medscape Medical News

Source: Medscape Medical News Headlines - March 1, 2017 Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news